Forte Biosciences, Inc. (FBRX)
76.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 13:46
Forte Biosciences Total Return Level : 76.95 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 76.95 |
| August 21, 2026 | 76.92 |
| August 20, 2026 | 76.89 |
| August 19, 2026 | 76.90 |
| August 18, 2026 | 76.88 |
| August 17, 2026 | 76.89 |
| August 14, 2026 | 76.83 |
| August 13, 2026 | 76.86 |
| August 12, 2026 | 76.78 |
| August 11, 2026 | 76.87 |
| August 10, 2026 | 76.82 |
| August 07, 2026 | 76.79 |
| August 06, 2026 | 76.83 |
| August 05, 2026 | 76.61 |
| August 04, 2026 | 76.56 |
| August 03, 2026 | 76.61 |
| July 31, 2026 | 76.60 |
| July 30, 2026 | 76.98 |
| July 29, 2026 | 76.53 |
| July 28, 2026 | 76.65 |
| July 27, 2026 | 76.50 |
| July 24, 2026 | 54.78 |
| July 23, 2026 | 59.70 |
| July 22, 2026 | 56.63 |
| July 21, 2026 | 50.73 |
| Date | Value |
|---|---|
| July 20, 2026 | 47.49 |
| July 17, 2026 | 48.86 |
| July 16, 2026 | 44.99 |
| July 15, 2026 | 44.15 |
| July 14, 2026 | 43.20 |
| July 13, 2026 | 44.12 |
| July 10, 2026 | 43.92 |
| July 09, 2026 | 36.70 |
| July 08, 2026 | 20.58 |
| July 07, 2026 | 22.25 |
| July 06, 2026 | 20.41 |
| July 02, 2026 | 20.92 |
| July 01, 2026 | 21.32 |
| June 30, 2026 | 21.25 |
| June 29, 2026 | 21.32 |
| June 26, 2026 | 21.03 |
| June 25, 2026 | 18.71 |
| June 24, 2026 | 18.54 |
| June 23, 2026 | 18.15 |
| June 22, 2026 | 18.28 |
| June 18, 2026 | 17.85 |
| June 17, 2026 | 17.59 |
| June 16, 2026 | 17.15 |
| June 15, 2026 | 18.05 |
| June 12, 2026 | 17.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| argenx SE | 1011.11 |
| ACADIA Pharmaceuticals, Inc. | 29.65 |
| Alnylam Pharmaceuticals, Inc. | 236.01 |
| Anika Therapeutics, Inc. | 21.34 |
| Savara, Inc. | 5.56 |